Explore our company news, announcements and updates

August 18, 2025

MSD Animal Health Presents New Data Highlighting Commitment to the Development and Study of Parasite Prevention and Treatment for Dogs at the 2025 World Association for the Advancement of Veterinary Parasitology Congress

July 24, 2025

European Commission Approves NUMELVI™ (atinvicitinib) Tablets for Dogs

July 10, 2025

FDA Approves BRAVECTO® QUANTUM (Fluralaner for Extended-Release Injectable Suspension) from MSD Animal Health

June 12, 2025

MSD Animal Health Receives Positive Opinion from CVMP for NOBIVAC® L6 and NOBIVAC® LoVo L6 Vaccines for Use in Dogs Against Leptospirosis

June 12, 2025

MSD Animal Health Receives EU CVMP Positive Opinion for NUMELVI™ (atinvicitinib) Tablets for Dogs

May 16, 2025

MSD Animal Health Receives Positive CVMP Opinion for INNOVAX®-ND-IBD-ILT for Use in Chickens

May 12, 2025

MSD Animal Health Demonstrates its Commitment to Ruminant Health at the 2025 European Buiatrics Congress

May 2, 2025

FDA Approves MSD Animal Health’s MOMETAMAX SINGLE™ to Treat Otitis Externa in Dogs

March 27, 2025

MSD Animal Health Announces the European Approval of NOBILIS MULTRIVA™ REOm for Use in Chickens

February 24, 2025

MSD Animal Health Announces New Agreement with Union Agener Animal Health for Worldwide Distributorship of LACTOTROPIN®

February 11, 2025

MSD Animal Health Wins 2024 S&P Global Award for Best New Companion Animal Product for injectable formulation of BRAVECTO® (fluralaner)

January 30, 2025

MSD Animal Health and Veterinarians of Europe (FVE) Reward 34 Veterinary Students from across Europe for Scholarship Program

Previous 123 Next